Genelux Ownership | Who Owns Genelux?
Genelux Ownership Summary
Genelux is owned by 19.19% institutional investors, 11.40% insiders, and 69.41% retail investors. Woodward diversified capital is the largest institutional shareholder, holding 4.69% of GNLX shares.
GNLX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Genelux | 19.19% | 11.40% | 69.41% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Woodward diversified capital | 1.78M | 4.69% | $5.10M |
| Bleichroeder lp | 714.00K | 1.88% | $2.05M |
| Blackrock funding, inc. /de | 324.98K | 0.86% | $932.70K |
| Alyeska investment group | 285.00K | 0.75% | $817.95K |
| Mai capital management | 236.55K | 0.62% | $678.91K |
| Provident wealth management | 158.87K | 0.42% | $455.95K |
| Lifesteps financial | 97.22K | 0.26% | $279.02K |
| Amg national trust bank | 75.35K | 0.20% | $216.26K |
| Flputnam investment management | 37.16K | 0.10% | $106.65K |
| Marshall wace, llp | 32.22K | 0.08% | $92.47K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Woodward diversified capital | 1.78M | 2.58% | $5.10M |
| Bleichroeder lp | 714.00K | 0.50% | $2.05M |
| Lifesteps financial | 97.22K | 0.19% | $279.02K |
| Provident wealth management | 158.87K | 0.15% | $455.95K |
| Kwb wealth | 23.33K | 0.01% | $62.98K |
| Beacon capital management | 19.12K | 0.01% | $54.86K |
| Liberty wealth management | 16.55K | 0.01% | $47.49K |
| Amg national trust bank | 75.35K | 0.01% | $216.26K |
| Mai capital management | 236.55K | 0.00% | $678.91K |
| United bank | 12.07K | 0.00% | $34.64K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Woodward diversified capital | 1.78M | 2.58% | 317.17K |
| Mai capital management | 236.55K | 0.00% | 236.20K |
| Flputnam investment management | 37.16K | 0.00% | 37.16K |
| Marshall wace, llp | 32.22K | 0.00% | 32.22K |
| Mariner | 30.03K | 0.00% | 30.03K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Heights capital management | - | - | -238.37K |
| Omers administration | - | - | -79.70K |
| Paloma partners management | - | - | -50.00K |
| Miracle mile advisors | - | - | -40.00K |
| Balyasny asset management | - | - | -35.63K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Flputnam investment management | 37.16K | 0.00% | 37.16K | $106.65K |
| Mariner | 30.03K | 0.00% | 30.03K | $86.19K |
| United bank | 12.07K | 0.00% | 12.07K | $34.64K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -8.00 |
| Allworth financial lp | -162.00 |
| Coldstream capital management | -175.00 |
| Tower research capital llc (trc) | -592.00 |
| Coppell advisory solutions | -3.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 59 | -21.33% | 7,281,681 | -0.23% | 19 | 4.39% | 25 | -46.81% | 12 | 9.09% |
| Mar 31, 2025 | 74 | 29.82% | 7,269,064 | 49.24% | 20 | 9.55% | 46 | 130.00% | 11 | -42.11% |
| Dec 31, 2024 | 57 | 1.79% | 4,870,849 | -6.84% | 14 | 6.44% | 20 | -4.76% | 19 | 11.76% |
| Sep 30, 2024 | 56 | -22.22% | 5,228,245 | -26.41% | 15 | 2.64% | 21 | -48.78% | 17 | -5.56% |
| Jun 30, 2024 | 72 | 9.09% | 7,104,517 | 18.07% | 23 | 4.76% | 41 | 7.89% | 18 | 20.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 12, 2025 | Ryder Sean | General Counsel | Sell | $13.07K |
| May 12, 2025 | Zindrick Thomas | President and CEO | Sell | $31.43K |
| May 12, 2025 | Yu Yong | VP, Clinical Trial Operations | Sell | $16.29K |
| May 12, 2025 | Cappello Joseph | VP, Pharmaceutical Development | Sell | $13.83K |
| May 12, 2025 | Smalling Ralph | Head of Regulatory | Sell | $3.68K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | 5 |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | 12 |
GNLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools